keyword
MENU ▼
Read by QxMD icon Read
search

Liraglutide AND Pediatric obesity

keyword
https://www.readbyqxmd.com/read/25366340/pharmacological-management-of-obesity-in-pediatric-patients
#1
REVIEW
Cassie L Boland, John Brock Harris, Kira B Harris
OBJECTIVE: To review current evidence of pharmacological options for managing pediatric obesity and provide potential areas for future research. DATA SOURCES: A MEDLINE search (1966 to October 2014) was conducted using the following keywords: exenatide, liraglutide, lorcaserin, metformin, obesity, orlistat, pediatric, phentermine, pramlintide, topiramate, weight loss, and zonisamide. STUDY SELECTION AND DATA EXTRACTION: Identified articles were evaluated for inclusion, with priority given to randomized controlled trials with orlistat, metformin, glucagon-like peptide-1 agonists, topiramate, and zonisamide in human subjects and articles written in English...
February 2015: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/25036533/liraglutide-s-safety-tolerability-pharmacokinetics-and-pharmacodynamics-in-pediatric-type-2-diabetes-a-randomized-double-blind-placebo-controlled-trial
#2
RANDOMIZED CONTROLLED TRIAL
David J Klein, Tadej Battelino, D J Chatterjee, Lisbeth V Jacobsen, Paula M Hale, Silva Arslanian
BACKGROUND: The prevalence of type 2 diabetes (T2D) in youth is increasing. Treatment options beyond metformin and insulin are needed. The safety, tolerability, pharmacokinetics, and pharmacodynamics of liraglutide once daily in youth (10-17 years old) with T2D were investigated in a randomized, double-blind, placebo-controlled trial. SUBJECTS AND METHODS: Youth treated with diet/exercise alone or with metformin and having a hemoglobin A1c (HbA1c) level of 6.5-11% were randomized to liraglutide (n=14) or placebo (n=7)...
October 2014: Diabetes Technology & Therapeutics
https://www.readbyqxmd.com/read/24222881/off-label-use-of-liraglutide-in-the-management-of-a-pediatric-patient-with-type-2-diabetes-mellitus
#3
Sara J Micale, Michael P Kane, Eileen Hogan
Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increases satiety, and delays gastric emptying. Liraglutide, unlike metformin and insulin, is not approved for use in the pediatric population. We report the successful off-label use of liraglutide in an obese, 16 year old Caucasian female with type 2 diabetes mellitus...
2013: Case Reports in Pediatrics
https://www.readbyqxmd.com/read/23782574/incretins-and-amylin-in-pediatric-diabetes-new-tools-for-management-of-diabetes-in-youth
#4
REVIEW
Jamie R Wood, Janet Silverstein
PURPOSE OF REVIEW: The purpose of this review is to examine recently published literature in the areas of incretins and amylin in the management of pediatric diabetes. RECENT FINDINGS: Recent studies have begun to explore the use of longer-acting GLP-1 analogues that can be given once daily, such as liraglutide, and the use of DPP-IV inhibitors in the management of type 2 diabetes. In addition, recent studies have been published on the use of exenatide in the management of pediatric obesity and newly diagnosed type 1 diabetes...
August 2013: Current Opinion in Pediatrics
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"